Press release content from Business Wire. The AP news staff was not involved in its creation. Aldevron Adds Self-Amplifying RNA to its Product Portfolio January 26, 2021 GMT FARGO, N.D.--(BUSINESS WIRE)--Jan 26, 2021-- Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins and mRNA for the biotech industry, announced today the addition of three reporter Self-amplifying RNA (saRNA) products to its growing catalog: Ald GFP saRNA™, Ald nLUC saRNA™. ADVERTISEMENT ALDsaRNA (Graphic: Business Wire) Alphavirus-derived saRNA encodes nonstructural proteins that enable self-replication, thereby allowing lower doses for genetic medicines and vaccines, and saRNA is being used to support next-generation COVID vaccine development. For these uses, Aldevron’s novel saRNA reporters enable rapid technology evaluation and delivery optimization.